BridgeBio Pharma
BBIO
BridgeBio Pharma (BBIO) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| JP Morgan | Maintained | Overweight | $111.00 from $100.00 | Aug 12, 2026 |
| Canaccord Genuity | Maintained | Buy | $106.00 from $104.00 | Aug 12, 2026 |
| Truist Securities | Maintained | Buy | $107.00 from $102.00 | Aug 12, 2026 |
| Wells Fargo | Maintained | Overweight | $102.00 from $98.00 | Aug 11, 2026 |
| Piper Sandler | Maintained | Overweight | $115.00 from $111.00 | Aug 11, 2026 |
| Morgan Stanley | Maintained | Overweight | $97.00 from $98.00 | Aug 11, 2026 |
| TD Cowen | Maintained | Buy | $110.00 from $95.00 | Aug 11, 2026 |
| B of A Securities | Maintained | Buy | $104.00 from $101.00 | Aug 11, 2026 |
| Citigroup | Maintained | Neutral | $93.00 from $82.00 | Jul 16, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $120.00 from $110.00 | Jul 13, 2026 |
| Mizuho | Maintained | Outperform | $96.00 from $106.00 | Jun 16, 2026 |
| Canaccord Genuity | Initiated Coverage | Buy | $104.00 | Jun 3, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $110.00 | May 28, 2026 |
| Morgan Stanley | Maintained | Overweight | $98.00 from $94.00 | May 28, 2026 |
| Raymond James | Downgraded | Outperform → Market Perform | — | May 26, 2026 |
| Citigroup | Initiated Coverage | Neutral | $82.00 | May 19, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $110.00 from $100.00 | May 11, 2026 |
| Evercore ISI Group | Maintained | Outperform | $130.00 from $125.00 | May 8, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $100.00 | Apr 29, 2026 |
| Truist Securities | Maintained | Buy | $102.00 from $95.00 | Apr 29, 2026 |
Frequently asked questions
What is the latest analyst rating on BBIO?
On Aug 12, 2026, JP Morgan maintained BridgeBio Pharma at Overweight with a price target of $111.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.